Atlas Trials

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

Clinical trial NCT00937183 · COMPLETED

Trial details

NCT number
NCT00937183
Sponsor
Jan Walewski
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Start date
2003-09-01
Primary completion
2017-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.